Evaluating the effects of oral hydrogen supplements in patients with chronic diseases
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
This study is testing whether taking hydrogen supplements can help people with chronic diseases feel better when combined with their regular treatments.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 20 Years to 80 Years |
| Sex | All |
| Sponsor | HoHo Biotech Industry-sponsored |
| Locations | 2 sites (Taipei and 1 other locations) |
| Trial ID | NCT06401785 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the efficacy and safety of oral hydrogen supplements in patients suffering from chronic diseases. Participants will receive hydrogen capsules alongside their conventional treatment for a duration of 24 weeks. The study will involve 60 patients who will be randomly assigned to either an experimental group receiving hydrogen capsules or a control group receiving placebo capsules. Health status, hematologic, and urine analyses will be conducted before and after the intervention to evaluate any changes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 20 to 80 with chronic inflammation or related conditions such as autoimmune diseases, metabolic disorders, or chronic kidney disease.
Not a fit: Patients who are pregnant, expect to become pregnant, or are currently participating in other clinical trials may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel adjunctive treatment option for patients with chronic diseases, potentially improving their recovery and health outcomes.
How similar studies have performed: International clinical trials have shown promise in the efficacy of hydrogen supplements for reducing chronic inflammation, suggesting that this approach may be viable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20 to 80 * Able to compliant with the protocol * Able to return to the hospital regularly * Patients with chronic inflammation, including patients with autoimmune diseases, metabolic-related diseases, chronic kidney disease or nephritis, tumor patients, etc. Exclusion Criteria: * Pregnancy * Expected pregnancy * Attending other clinical trials with 6 months
Where this trial is running
Taipei and 1 other locations
- Tri-Service General Hospital — Taipei, Taiwan (Recruiting)
- Taoyuan Armed Forces General Hospital — Taoyuan, Taiwan (Recruiting)
Study contacts
- Study coordinator: Kuang-Yih Wang, M.D.
- Email: bbban1024@gmail.com
- Phone: +886 920757313
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.